During the past decade, Huizhou Municipal Central Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 1 clinical trials were completed. i.e. 7.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Huizhou Municipal Central Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "ADC Therapeutics S.A." with 1 trials sponsored, "Ark Biosciences Inc." with 1 trials sponsored, "Chinese Academy of Medical Sciences, Fuwai Hospital" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Huizhou Municipal Central Hospital" #1 collaborator was "Huizhou Municipal Central Hospital" with 2 trials as a collaborator, "Changsha Central Hospital" with 1 trials as a collaborator, "Changzhi People's Hospital" with 1 trials as a collaborator, "Chaozhou Central Hospital" with 1 trials as a collaborator and "Dongguan People's Hospital" with 1 trials as a collaborator. Other collaborators include 35 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "Huizhou Municipal Central Hospital" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials), "Carcinoma, Non-small-Cell Lung" (1 trials), "Coronavirus Disease 2019" (1 trials) and "Influenza A" (1 trials). Many other conditions were trialed in "Huizhou Municipal Central Hospital" in a lesser frequency.

Most popular intervention types in "Huizhou Municipal Central Hospital" are "Drug" (12 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amivantamab" (4 trials), "Lazertinib" (4 trials), "Placebo" (4 trials), "Carboplatin" (2 trials) and "Pemetrexed" (2 trials). Other intervention names were less common.

The vast majority of trials in "Huizhou Municipal Central Hospital" are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Huizhou Municipal Central Hospital". undefined are not yet recruiting, 8 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Huizhou Municipal Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Huizhou Municipal Central Hospital, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".